Short Interest in Jamieson Wellness Inc. (OTCMKTS:JWLLF) Declines By 76.6%

Jamieson Wellness Inc. (OTCMKTS:JWLLF) was the recipient of a significant drop in short interest in August. As of August 14th, there was short interest totaling 94,875 shares, a drop of 76.6% from the July 30th total of 404,709 shares. Based on an average trading volume of 6,636 shares, the days-to-cover ratio is presently 14.3 days.

Analyst Upgrades and Downgrades

Several analysts have issued reports on JWLLF shares. National Bank Financial restated an “outperform” rating on shares of Jamieson Wellness in a research report on Friday, June 26th. Canadian Imperial Bank of Commerce reissued an “outperform” rating on shares of Jamieson Wellness in a research note on Friday, May 8th. Royal Bank Of Canada lowered Jamieson Wellness from an “outperform” rating to a “sector perform” rating in a research report on Monday, August 10th. Finally, Citigroup cut Jamieson Wellness to a “hold” rating in a research note on Friday, August 7th. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy”.

Jamieson Wellness Stock Performance

Shares of JWLLF stock remained flat at $32.91 during mid-day trading on Thursday. 500 shares of the company’s stock were exchanged, compared to its average volume of 5,178. The company has a 50-day moving average price of $30.11 and a 200-day moving average price of $27.07. Jamieson Wellness has a 12-month low of $23.88 and a 12-month high of $33.15.

About Jamieson Wellness

Jamieson Wellness is a leading Canadian manufacturer and distributor of nutraceutical products, including vitamins, minerals, herbal remedies and dietary supplements. Founded in 1922, the company has grown to offer a diverse portfolio of formulations designed to support general health, immune function, digestion and other specialized wellness needs. Its flagship Jamieson brand is complemented by sub-brands such as bkind, reflecting a commitment to innovation and consumer choice across a range of tablet, capsule and gummy formats.

The company serves both domestic and international markets through a multi-channel approach that includes major mass and drug retailers, specialty stores and direct-to-consumer e-commerce platforms.